Australian Council on Healthcare Standards - National Quality Measures Clearinghouse | Dermatological consult - Phototherapy - Skin tumour -

Australian Council on Healthcare Standards

1. Dermatological consult: percentage of patients who receive a dermatological consult within 24 hours, greater than or equal to 1 day and less than 2 days, greater than or equal to 2 days and less than 5 working days, or longer than one week after the primary contact time to assessment visit, during the 6 month time period. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Dermatological consult: percentage of patients who receive a dermatological consult within 24 hours, greater than or equal to 1 day and less than 2 days, greater than or equal to 2 days and less than 5 working days, or longer than one week after the primary contact time to assessment visit, during the 6 month time period.


2. Phototherapy: percentage of patients receiving broad band UVB phototherapy, during the 6 month time period. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Phototherapy: percentage of patients receiving broad band UVB phototherapy, during the 6 month time period.


3. Phototherapy: percentage of patients receiving narrow band UVB phototherapy, during the 6 month time period. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Phototherapy: percentage of patients receiving narrow band UVB phototherapy, during the 6 month time period.


4. Phototherapy: percentage of patients receiving UVB phototherapy for eczema, during the 6 month time period. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Phototherapy: percentage of patients receiving UVB phototherapy for eczema, during the 6 month time period.


5. Phototherapy: percentage of patients receiving UVB phototherapy for other dermatoses, during the 6 month time period. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Phototherapy: percentage of patients receiving UVB phototherapy for other dermatoses, during the 6 month time period.


6. Phototherapy: percentage of patients receiving UVB phototherapy for psoriasis, during the 6 month time period. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Phototherapy: percentage of patients receiving UVB phototherapy for psoriasis, during the 6 month time period.


7. Phototherapy: percentage of patients receiving UVB phototherapy where a protocol for dose and documentation of side effects were used, during the 6 month time period. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Phototherapy: percentage of patients receiving UVB phototherapy where a protocol for dose and documentation of side effects were used, during the 6 month time period.


8. Phototherapy: percentage of patients receiving UVB phototherapy where there is documented evidence of the explanation of phototherapy and side effects, during the 6 month time period. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Phototherapy: percentage of patients receiving UVB phototherapy where there is documented evidence of the explanation of phototherapy and side effects, during the 6 month time period.


9. Phototherapy: percentage of patients receiving UVB phototherapy where there is documented evidence of the total UVB dose administered, during the 6 month time period. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Phototherapy: percentage of patients receiving UVB phototherapy where there is documented evidence of the total UVB dose administered, during the 6 month time period.


10. Phototherapy: percentage of patients receiving UVB phototherapy where there is documented evidence of treatment outcome at the conclusion of the phototherapy course, during the 6 month time period. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Phototherapy: percentage of patients receiving UVB phototherapy where there is documented evidence of treatment outcome at the conclusion of the phototherapy course, during the 6 month time period.


11. Phototherapy: percentage of patients receiving UVB phototherapy where there is documented evidence of written informed consent, during the 6 month time period. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Phototherapy: percentage of patients receiving UVB phototherapy where there is documented evidence of written informed consent, during the 6 month time period.


12. Phototherapy: percentage of patients receiving UVB phototherapy where there is documented evidence that contraindications were considered, during the 6 month time period. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Phototherapy: percentage of patients receiving UVB phototherapy where there is documented evidence that contraindications were considered, during the 6 month time period.



13. Skin tumour pathology (biopsy book): percentage of histopathology specimens taken with a skin tumour working diagnosis, during the 6 month time period. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Skin tumour pathology (biopsy book): percentage of histopathology specimens taken with a skin tumour working diagnosis, during the 6 month time period.


14. Skin tumour pathology (biopsy book): percentage of patients for whom management lag time was less than 1 working day, greater than or equal to 1 working day and less than 5 working days, and greater than or equal to 5 working days and less than 2 weeks, during the 6 month time period. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Skin tumour pathology (biopsy book): percentage of patients for whom management lag time was less than 1 working day, greater than or equal to 1 working day and less than 5 working days, and greater than or equal to 5 working days and less than 2 weeks, during the 6 month time period.


15. Skin tumour pathology (biopsy book): percentage of patients for whom patient information lag time was less than 1 working day, greater than or equal to 1 working day and less than 5 working days, and greater than or equal to 5 working days and less than 2 weeks, during the 6 month time period. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Skin tumour pathology (biopsy book): percentage of patients for whom patient information lag time was less than 1 working day, greater than or equal to 1 working day and less than 5 working days, and greater than or equal to 5 working days and less than 2 weeks, during the 6 month time period.


16. Skin tumour pathology (biopsy book): percentage of patients for whom time to review was less than 2 working days, greater than or equal to 2 working days and less than 5 working days, and greater than or equal to 5 working days and less than 2 weeks, during the 6 month time period. This updates a previously published measure summary.

full-text:
National Quality Measures Clearinghouse | Skin tumour pathology (biopsy book): percentage of patients for whom time to review was less than 2 working days, greater than or equal to 2 working days and less than 5 working days, and greater than or equal to 5 working days and less than 2 weeks, during the 6 month time period.